Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/wiley/in-vitro-immunosuppressive-activity-of-soluble-hla-class-i-and-fas-JVIwDGS7oR
References (61)
-
S. Fournel, M. Aguerre‐Girr, X. Huc, F. Lenfant, A. Alam, A. Toubert, A. Bensussan, P. Bouteiller (2000)
Cutting Edge: Soluble HLA-G1 Triggers CD95/CD95 Ligand-Mediated Apoptosis in Activated CD8+ Cells by Interacting with CD81The Journal of Immunology, 164
-
W. Dzik, A. Fleisher, D. Ciavarella, K. Karlson, G. Reed, R. Berger (1992)
Safety and efficacy of autologous blood donation before elective aortic valve operation.The Annals of thoracic surgery, 54 6
-
M. Sayegh, C. Carpenter (1996)
Role of indirect allorecognition in allograft rejection.International reviews of immunology, 13 3
-
S. Dzik, M. Blajchman, N. Blumberg, S. Kirkley, J. Heal, K. Wood (1996)
Current Research on the Immunomodulatory Effect of Allogeneic Blood TransfusionVox Sanguinis, 70
-
M. Temponi, U. Kekish, C. Hamby, H. Nielsen, C. Marboe, S. Ferrone (1993)
Characterization of anti-HLA class II monoclonal antibody LGII-612.14 reacting with formalin fixed tissues.Journal of immunological methods, 161 2
-
S. Comuzio, A. Orlandini, F. Grillo, F. Puppo, R. Ruzzenenti, S. Brenci, L. Lanza, M. Scudeletti, F. Indiveri (1991)
Simple elisa method for the evaluation of soluble hla class i antigens in human serumJournal of Clinical Laboratory Analysis, 5
-
A. Shanwell, M. Kristiansson, M. Remberger, O. Ringdén (1997)
Generation of cytokines in red cell concentrates during storage is prevented by prestorage white cell reductionTransfusion, 37
-
A. Bøyum (1968)
Separation of leukocytes from blood and bone marrow. Introduction.Scandinavian Journal of Clinical & Laboratory Investigation, 97
-
Riccardo Gavioli, M Kurilla, P. Campos-Lima, L. Wallace, Riccardo Dolcetti, R. Murray, A. Rickinson, M. Masucci (1993)
Multiple HLA A11-restricted cytotoxic T-lymphocyte epitopes of different immunogenicities in the Epstein-Barr virus-encoded nuclear antigen 4Journal of Virology, 67
-
J. Rood, A. Leeuwen, M. Santen (1970)
Anti HL-A2 Inhibitor in Normal Human SerumNature, 226
-
R. Domen (1998)
Adverse reactions associated with autologous blood transfusion: evaluation and incidence at a large academic hospitalTransfusion, 38
-
M. Tanabe, Masayuki Sekimata, Soldano Ferrone, Masafumi Takiguchi (1992)
Structural and functional analysis of monomorphic determinants recognized by monoclonal antibodies reacting with the HLA class I alpha 3 domain.Journal of immunology, 148 10
-
M. Ghio, P. Contini, C. Mazzei, S. Brenci, G. Barberis, G. Filaci, F. Indiveri, F. Puppo (1999)
Soluble HLA Class I, HLA Class II, and Fas Ligand in Blood Components: A Possible Key to Explain the Immunomodulatory Effects of Allogeneic Blood TransfusionsBlood, 93
-
D. Owings, M. Kruskall, R. Thurer, L. Donovan (1989)
Autologous blood donations prior to elective cardiac surgery. Safety and effect on subsequent blood use.JAMA, 262
-
M. Martínez-Lorenzo, A. Anel, S. Gamen, Inmaculada Monleón, P. Lasierra, L. Larrad, A. Piñeiro, M. Alava, Javier Naval (1999)
Activated human T cells release bioactive Fas ligand and APO2 ligand in microvesicles.Journal of immunology, 163 3
-
Vox Sanguinis (1998)
Changes in Donor Leukocytes during Blood Storage. Implications on Post‐ Transfusion Immunomodulation and Transfusion‐Associated GVHDVox Sanguinis, 74
-
M. Pellegrino, A. Ng, C. Russo, S. Ferrone (1982)
HETEROGENEOUS DISTRIBUTION OF THE DETERMINANTS DEFINED BY MONOCLONAL ANTIBODIES ON HLA‐A AND B ANTIGENS BEARING MOLECULESTransplantation, 34
-
T. Suda, T. Okazaki, Y. Naito, T. Yokota, N. Arai, Shoichi Ozaki, K. Nakao, S. Nagata (1995)
Expression of the Fas ligand in cells of T cell lineage.Journal of immunology, 154 8
-
M. Mincheff, D. Loukinov, S. Zoubak, M. Hammett, H. Meryman (1998)
Fas and Fas Ligand Expression on Human Peripheral Blood LeukocytesVox Sanguinis, 74
-
C. Barnstable, W. Bodmer, Graham Brown, G. Galfré, C. Milstein, A. Williams, A. Ziegler (1978)
Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysisCell, 14
-
E. Vamvakas, M. Blajchman (2001)
Deleterious clinical effects of transfusion-associated immunomodulation: fact or fiction?Blood, 97 5
-
W. Liles, P. Kiener, J. Ledbetter, A. Aruffo, S. Klebanoff (1996)
Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: implications for the regulation of apoptosis in neutrophilsThe Journal of Experimental Medicine, 184
-
E. Vmvakas, S. Moore (1994)
Blood transfusion and postoperative septic complicationsTransfusion, 34
-
A. Martelli, P. Tazzari, R. Bortul, M. Riccio, G. Tabellini, S. Santi, F. Frabetti, D. Musiani, R. Bareggi, R. Conte (2000)
Nuclear matrix protein is released from apoptotic white cells during cold (1‐6°C) storage of concentrated red cell units and might induce antibody response in multiply transfused patientsTransfusion, 40
-
R. Hausmann, N. Zavazava, J. Steinmann, W. Müller‐ruchholtz (1993)
Interaction of papain‐digested HLA class I molecules with human alloreactive cytotoxic T lymphocytes (CTL)Clinical & Experimental Immunology, 91
-
JP Allison, MA Pellegrino, S Ferrone (1977)
Biologic and chemical characterization of HLA molecules in human serum.J Immunol, 118
-
L. Parijs, A. Abbas (1996)
Role of Fas-mediated cell death in the regulation of immune responses.Current opinion in immunology, 8 3
-
LM Dobbe, NJ Stam, JJ Neefjes, MJ Giphart (1988)
Biochemical complexity of serum HLA class I molecules.Immunogenetics, 27
-
N. Zavazava, M. Krönke (1996)
Soluble HLA class I molecules induce apoptosis in alloreactive cytotoxic T lymphocytesNature Medicine, 2
-
Dose-response effects of sHLA-I and sFasL on CTC activity (A and B), MLR (C and D), and apoptosis induction (E and F) -
F. Puppo, D. Bignardi, P. Contini, C. Hamby, S. Brenci, L. Lanza, M. Ghio, M. Scudeletti, F. Indiveri, S. Ferrone (1999)
β2‐μ‐free HLA class I heavy chain levels in sera of healthy individuals. Lack of association with β2‐μ‐associated HLA class I heavy chain levels and HLA phenotypeTissue Antigens, 53
-
S. Santoso, V. Kiefel, H. Volz, C. Mueller-Eckhardt (1992)
Quantitation of Soluble HLA Class I Antigen in Human Albumin and Immunoglobulin Preparations for Intravenous Use by Solid‐Phase ImmunoassayVox Sanguinis, 62
-
B. Gansuvd, M. Hagihara, B. Munkhbat, N. Kanai, N. Morita, N. Munkhtuvshin, J. Chargui, S. Kato, T. Hotta, K. Tsuji (2000)
Inhibition of Epstein–Barr virus (EBV)‐specific CD8+ cytotoxic T lymphocyte (CTL) activity by soluble HLA class I in vitroClinical & Experimental Immunology, 119
-
P. Ness, P. Walsh, M. Zahurak, M. Baldwin, S. Piantadosi (1992)
Prostate cancer recurrence in radical surgery patients receiving autologous or homologous bloodTransfusion, 32
-
S Comuzio, F Puppo, R Ruzzenenti (1991)
Simple ELISA method for the evaluation of soluble HLA class I antigens in human serum.J Lab Clin Anal, 5
-
P. Parham, C. Clayberger, S. Zorn, D. Ludwig, G. Schoolnik, A. Krensky (1987)
Inhibition of alloreactive cytotoxic T lymphocytes by peptides from the α2 domain of HLA–A2Nature, 325
-
Masato Tanaka, T. Suda, K. Haze, N. Nakamura, Kenziro Sato, F. Kimura, K. Motoyoshi, M. Mizuki, S. Tagawa, S. Ohga, K. Hatake, A. Drummond, S. Nagata (1996)
Fas ligand in human serumNature Medicine, 2
-
W. Pickl, O. Majdic, I. Faé, R. Reuschel, W. Holter, W. Knapp (1993)
The soluble pool of beta 2-microglobulin free HLA class I alpha-chains. Qualitative and quantitative characterization.Journal of immunology, 151 5
-
A. Sauaia, W. Alexander, E. Moore, B. Stevens, H. Rosen, T. Dunn (1999)
Autologous blood transfusion does not reduce postoperative infection rates in elective surgery.American journal of surgery, 178 6
-
H. Grosse-wilde, R. Blasczyk, U. Westhoff (1992)
Soluble HLA class I and class II concentrations in commercial immunoglobulin preparations.Tissue antigens, 39 2
-
G. Filaci, P. Contini, S. Brenci, L. Lanza, M. Scudeletti, F. Indiveri, F. Puppo (1995)
Increased serum concentration of soluble HLA-DR antigens in HIV infection and following transplantation.Tissue antigens, 46 2
-
R. Blasczyk, U. Westhoff, H. Grosse-wilde (1993)
Soluble CD4, CD8, and HLA molecules in commercial immunoglobulin preparationsThe Lancet, 341
-
M. Forgie, Philip Wells, Andreas Laupacis, Dean Fergusson (1998)
Preoperative autologous donation decreases allogeneic transfusion but increases exposure to all red blood cell transfusion: results of a meta-analysis. International Study of Perioperative Transfusion (ISPOT) Investigators.Archives of internal medicine, 158 6
-
F. Puppo, P. Contini, M. Ghio, S. Brenci, M. Scudeletti, G. Filaci, S. Ferrone, F. Indiveri (2000)
Soluble human MHC class I molecules induce soluble Fas ligand secretion and trigger apoptosis in activated CD8(+) Fas (CD95)(+) T lymphocytes.International immunology, 12 2
-
B. Wilson, F. Indiveri, M. Pellegrino, S. Ferrone (1979)
Production and characterization of DR xenoantisera: use for detection of serum DR antigens.Journal of immunology, 122 5
-
J. Allison, M. Pellegrino, S. Ferrone, G. Callahan, R. Reisfeld (1977)
Biologic and chemical characterization of HLA antigens in human serum.Journal of immunology, 118 3
-
N. Stam, H. Spits, H. Ploegh (1986)
Monoclonal antibodies raised against denatured HLA-B locus heavy chains permit biochemical characterization of certain HLA-C locus products.Journal of immunology, 137 7
-
Frank Sonnenberg, P. Gregory, R. Yomtovian, Louise Russell, William Tierney, M. Kosmin, Jeffrey Carson (1999)
The cost‐effectiveness of autologous transfusion revisited: implications of an increased risk of bacterialinfection with allogeneic transfusionTransfusion, 39
-
S. Nagata (1994)
Fas and Fas ligand: a death factor and its receptor.Advances in immunology, 57
-
M. Heiss, P. Fraunberger, C. Delanoff, R. Stets, H. Allgayer, M. Ströhlein, A. Tarabichi, E. Faist, K. Jauch, F. Schildberg (1995)
MODULATION OF IMMUNE RESPONSE BY BLOOD TRANSFUSION: EVIDENCE FOR A DIFFERENTIAL EFFECT OF ALLOGENEIC AND AUTOLOGOUS BLOOD IN COLORECTAL CANCER SURGERYShock, 4
-
F. Frabetti, D. Musiani, M. Marini, C. Fanelli, Simona Coppola, L. Ghibelli, P. Tazzari, A. Bontadini, C. Tassi, R. Conte (2008)
White cell apoptosis in packed red cellsTransfusion, 38
-
S. Dzik, P. Szuflad, S. Eaves (1994)
HLA Antigens on Leukocyte Fragments and Plasma Proteins: Prestorage Leukoreduction by FiltrationVox Sanguinis, 66
-
Jean-Yves Dupuis, Bevin Bart, Gregory Bryson, James Robblee (1999)
Transfusion practices among patients who did and did not predonate autologous blood before elective cardiac surgery.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 160 7
-
W. Ross (1993)
Blood transfusions and prognosis in colorectal cancer.The New England journal of medicine, 329 18
-
U. Westhoff, H. Grosse-wilde (1995)
Soluble HLA Class I and Class II Concentrations in Factor VIII and PCC PreparationsVox Sanguinis, 68
-
M. Blajchman, J. Bordin (1994)
Mechanisms of transfusion-associated immunosuppression.Current opinion in hematology, 1 6
-
S. James (1994)
Measurement of Proliferative Responses of Cultured LymphocytesCurrent Protocols in Immunology, 11
-
M. Blajchman (1997)
Allogeneic blood transfusions, immunomodulation, and postoperative bacterial infection: Do we have the answers yet?Transfusion, 37
-
A. Böyum (1968)
Separation of leukocytes from blood and bone marrow. Introduction.Scandinavian journal of clinical and laboratory investigation. Supplementum, 97
-
Paola Contini, M. Ghio, Andrea Merlo, S. Brenci, G. Filaci, Francesco Indiveri, Francesco Puppo (2000)
Soluble HLA class I/CD8 ligation triggers apoptosis in EBV-specific CD8+ cytotoxic T lymphocytes by Fas/Fas-ligand interaction.Human immunology, 61 12
-
V Quaranta, N Tanigaki, S Ferrone (1981)
Distribution of antigenic determinants recognized by three monoclonal antibodies (Q2/70, Q5/6 and Q5/13) on human Ia‐like alloantigens and on their subunits.Immunogenetics, 12
- Publisher
- Wiley
- Copyright
- Copyright © 2001 Wiley Subscription Services
- ISSN
- 0041-1132
- eISSN
- 1537-2995
- DOI
- 10.1046/j.1537-2995.2001.41080988.x
- Publisher site
- See Article on Publisher Site
Abstract
BACKGROUND: The immunomodulatory effects of allogeneic blood transfusion may contribute to a poor prognosis in patients with cancer who are undergoing surgery, and clinical trials have been carried out to investigate whether these patients would benefit from autologous blood donation. As the immunomodulatory effects of allogeneic blood transfusion have been related to soluble molecules released from residual WBCs during storage, the in vitro immunomodulatory activity of soluble molecules detected in supernatants from stored autologous blood was evaluated.
Journal
Transfusion – Wiley
Published: Jan 1, 2001
Keywords: ; ; ; ; ; ; ; ; ; ; ; ; ; ;